The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

Abstract Background Triple Negative Breast Cancers (TNBCs) lack the appropriate targets for currently used breast cancer therapies, conferring an aggressive phenotype, more frequent relapse and poorer survival rates. The biological heterogeneity of TNBC complicates the clinical treatment further. We...

Full description

Bibliographic Details
Main Authors: Shavira Narrandes, Shujun Huang, Leigh Murphy, Wayne Xu
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Cancer
Subjects:
Triple Negative Breast Cancer
Pathway
Drug target
FOXM1
PPARα
Online Access:http://link.springer.com/article/10.1186/s12885-017-3939-4

Internet

http://link.springer.com/article/10.1186/s12885-017-3939-4

Similar Items